Search results for "innovation"
Article
A Bright Future for the Plasma Fractionation Industry
In addition, a poster session allowed for an open discussion around some of the latest trends and innovations within the industry in combination with excellent networking opportunities.
The meet…
Article
Biosimilars Will Bring Significant Litigation and Patent Challenges
Even though one of the key objectives of the Biologics Price Competition and Innovation Act (BPCIA) is to identify and limit the number of patents that can be the subject of litigation, according to E…
Article
New Era for Generic Drugs
Manufacturers face regulatory overhaul, while brand-generic debates escalate over biosimilars and labeling changes.
Nov 1, 2014
By: Jill Wechsler
BioPharm International
Volume 11, Issue …
Article
EMA Collaborates with HTA Assessment Networks
High technology assessments are having an impact on biosimilars development in Europe.
Gaining access to Europe’s pharmaceutical markets has become a multi-stage operation. The licensing of a…
Article
Report from the Eighth International Plasma Product Biotechnology Meeting Melia Salinas, Lanzarote, Spain
The meeting focusing on the trends and innovations within the field of plasma fractionation and plasma products, was held in May on the island of Lanzarote, Spain. The PPB meeting has since the start …
Article
From Bottlenecks to Breakthroughs: Mastering Buffer Management
Unlock innovation in manufacturing by optimizing your buffer production.
Agenda
- Options to intensify buffer preparation from using pre-made buffers or buffer concentrates to impl…
Article
Take part of the Southeast Asia BioChallenge
Looking to create the next breakthrough innovation? Cytiva is here to support you to bring your molecule to market in the shortest possible time. By applying to our BioChallenge, you stand …
Article
Single-Use Technologies Prove Effective for Viral Vector Process Development
Residual activated trypsin can also inactivate many viral vectors,” says to Natraj Ram, vice-president of innovation in Thermo Fisher Scientific’s BioProduction business.
Adherent processes, Sande…
Article
Commercial Production of Gene Therapies Using Suspension or Adherent Cell Lines
Recent technological innovations provide substitute solutions. The development of breakthrough FBRs bring new opportunities in readily developing and scaling adherent platforms as an alternative to ST…
Article
The Importance of Process Intensification and PAT for Achieving Real-Time Release
The emergence of industry-led consortia to support the development of manufacturing innovations for the biopharma industry provides a foundation for de-risking some of these activities. The National I…